The preset invention relates to a biomarker for identifying the subgroup of early stage lung adenocarcinoma patients in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated protein kinase , and {HEAD ~ a therapeutic target} for {TAIL ~ lung cancer} 
for
The preset invention relates to a biomarker for identifying the subgroup of early stage lung adenocarcinoma patients in early stage non small cell lung cancer , which is T lymphokine activated killer cell originated protein kinase , and { HEAD ~ a therapeutic target } for { TAIL ~ lung cancer }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL